title: A novel GABA(A)  receptor pharmacology: drugs interacting with the α(+) β(-)  interface.
abstract: GABA(A)  receptors are ligand-gated chloride channels composed of five subunits that can belong to different subunit classes. The existence of 19 different subunits gives rise to a multiplicity of GABA(A)  receptor subtypes with distinct subunit composition; regional, cellular and subcellular distribution; and pharmacology. Most of these receptors are composed of two α, two β and one γ2 subunits. GABA(A)  receptors are the site of action of a variety of pharmacologically and clinically important drugs, such as benzodiazepines, barbiturates, neuroactive steroids, anaesthetics and convulsants. Whereas GABA acts at the two extracellular β(+) α(-)  interfaces of GABA(A)  receptors, the allosteric modulatory benzodiazepines interact with the extracellular α(+) γ2(-)  interface. In contrast, barbiturates, neuroactive steroids and anaesthetics seem to interact with solvent accessible pockets in the transmembrane domain. Several benzodiazepine site ligands have been identified that selectively interact with GABA(A)  receptor subtypes containing α2βγ2, α3βγ2 or α5βγ2 subunits. This indicates that the different α subunit types present in these receptors convey sufficient structural differences to the benzodiazepine binding site to allow specific interaction with certain benzodiazepine site ligands. Recently, a novel drug binding site was identified at the α(+) β(-)  interface. This binding site is homologous to the benzodiazepine binding site at the α(+) γ2(-)  interface and is thus also strongly influenced by the type of α subunit present in the receptor. Drugs interacting with this binding site cannot directly activate but only allosterically modulate GABA(A)  receptors. The possible importance of such drugs addressing a spectrum of receptor subtypes completely different from that of benzodiazepines is discussed.
authors.affiliation: Department of Biochemistry and Molecular Biology, Center for Brain Research, Medical University Vienna, Vienna, Austria.
authors.forename: Werner
authors.initials: W
authors.lastname: Sieghart
authors.forename: Joachim
authors.initials: J
authors.lastname: Ramerstorfer
authors.forename: Isabella
authors.initials: I
authors.lastname: Sarto-Jackson
authors.forename: Zdravko
authors.initials: Z
authors.lastname: Varagic
authors.forename: Margot
authors.initials: M
authors.lastname: Ernst
mesh_terms: D000818:Animals; D001569:Benzodiazepines / Q000378:metabolism; D006801:Humans; D004364:Pharmaceutical Preparations / Q000378:metabolism; D021122:Protein Subunits / Q000737:chemistry / Q000378:metabolism*; D011963:Receptors, GABA-A / Q000737:chemistry / Q000378:metabolism*
chemical_list: D004364:Pharmaceutical Preparations; D021122:Protein Subunits; D011963:Receptors, GABA-A; D001569:Benzodiazepines
references.citation: J Neurosci. 2003 May 1;23(9):3649-57
references.pmid: 12736336
references.citation: Proc Natl Acad Sci U S A. 1994 May 10;91(10):4569-73
references.pmid: 8183949
references.citation: Can J Anaesth. 2011 Feb;58(2):206-15
references.pmid: 21194017
references.citation: Neurochem Int. 2004 Jun;44(7):539-47
references.pmid: 15209422
references.citation: Nature. 2008 Jan 17;451(7176):330-4
references.pmid: 18202657
references.citation: J Neurosci. 2001 Mar 15;21(6):RC136
references.pmid: 11245705
references.citation: Proc Natl Acad Sci U S A. 2006 Apr 18;103(16):6081-2
references.pmid: 16606858
references.citation: Proc Natl Acad Sci U S A. 2005 Nov 22;102(47):17154-9
references.pmid: 16284244
references.citation: Proc Natl Acad Sci U S A. 2001 May 22;98(11):6464-9
references.pmid: 11353839
references.citation: Neuropharmacology. 2009 Jan;56(1):141-8
references.pmid: 18760291
references.citation: Br J Pharmacol. 2004 May;142(1):97-106
references.pmid: 15100159
references.citation: Eur J Neurosci. 2010 Dec;32(11):1868-88
references.pmid: 21073549
references.citation: J Pharmacol Exp Ther. 2006 Jan;316(1):410-22
references.pmid: 16183706
references.citation: Neuropharmacology. 2011 Mar;60(4):626-32
references.pmid: 21145329
references.citation: J Med Chem. 2009 Apr 9;52(7):1795-8
references.pmid: 19275170
references.citation: Brain Res. 2008 May 7;1208:150-9
references.pmid: 18394590
references.citation: J Biol Chem. 2010 Jul 30;285(31):23985-93
references.pmid: 20511229
references.citation: J Physiol. 2006 Dec 1;577(Pt 2):569-77
references.pmid: 16990398
references.citation: ChemMedChem. 2010 May 3;5(5):678-81
references.pmid: 20235267
references.citation: Proc Natl Acad Sci U S A. 2006 May 30;103(22):8546-51
references.pmid: 16581914
references.citation: Bioorg Med Chem Lett. 2009 Oct 1;19(19):5746-52
references.pmid: 19726184
references.citation: Proc Natl Acad Sci U S A. 1999 Aug 17;96(17):9891-6
references.pmid: 10449790
references.citation: Pharmacol Ther. 2007 Oct;116(1):7-19
references.pmid: 17560657
references.citation: J Neurosci. 1998 Mar 1;18(5):1693-703
references.pmid: 9464994
references.citation: CNS Drug Rev. 2003 Spring;9(1):3-20
references.pmid: 12595909
references.citation: Neuropharmacology. 2001 Dec;41(8):952-64
references.pmid: 11747900
references.citation: Eur J Neurosci. 1999 Jan;11(1):41-50
references.pmid: 9987010
references.citation: Br J Pharmacol. 2000 Oct;131(4):843-50
references.pmid: 11030736
references.citation: Br J Pharmacol. 2005 Feb;144(3):357-66
references.pmid: 15655523
references.citation: J Pharmacol Exp Ther. 2006 Mar;316(3):1335-45
references.pmid: 16326923
references.citation: J Neurosci. 1997 Apr 15;17(8):2728-37
references.pmid: 9092594
references.citation: J Gen Physiol. 2007 Feb;129(2):145-59
references.pmid: 17227918
references.citation: J Biol Chem. 1999 Jul 9;274(28):19613-6
references.pmid: 10391897
references.citation: Nat Neurosci. 2000 Dec;3(12):1274-81
references.pmid: 11100148
references.citation: Neuroscience. 2002;111(3):657-69
references.pmid: 12031352
references.citation: Proc Natl Acad Sci U S A. 1997 Sep 30;94(20):11031-6
references.pmid: 9380754
references.citation: J Med Chem. 1982 Apr;25(4):337-9
references.pmid: 6121916
references.citation: Mol Pharmacol. 2006 Feb;69(2):640-9
references.pmid: 16272224
references.citation: Annu Rev Pharmacol Toxicol. 2001;41:23-51
references.pmid: 11264449
references.citation: Br J Pharmacol. 1997 Mar;120(5):749-56
references.pmid: 9138677
references.citation: J Psychopharmacol. 2011 Mar;25(3):314-28
references.pmid: 20147571
references.citation: Neuropharmacology. 2009 Jan;56(1):149-54
references.pmid: 18762201
references.citation: J Neurosci. 2011 Jan 19;31(3):870-7
references.pmid: 21248110
references.citation: Science. 2000 Oct 6;290(5489):131-4
references.pmid: 11021797
references.citation: J Neurochem. 2001 Dec;79(5):1100-8
references.pmid: 11739624
references.citation: Mol Neurobiol. 1998 Aug;18(1):35-86
references.pmid: 9824848
references.citation: Bioorg Med Chem Lett. 2009 Oct 15;19(20):5958-61
references.pmid: 19740657
references.citation: J Biol Chem. 1999 Apr 9;274(15):10100-4
references.pmid: 10187791
references.citation: J Neurosci. 2002 Jul 1;22(13):5572-80
references.pmid: 12097508
references.citation: FASEB J. 2003 Feb;17(2):250-2
references.pmid: 12475885
references.citation: Trends Pharmacol Sci. 1997 Nov;18(11):425-9
references.pmid: 9426470
references.citation: Trends Pharmacol Sci. 1995 May;16(5):162-8
references.pmid: 7624971
references.citation: J Biol Chem. 2010 Mar 19;285(12):8615-20
references.pmid: 20083606
references.citation: Br J Pharmacol. 2010 Sep;161(1):65-78
references.pmid: 20718740
references.citation: Eur J Neurosci. 2000 Dec;12(12):4318-30
references.pmid: 11122342
references.citation: J Biol Chem. 1997 Jun 13;272(24):15346-50
references.pmid: 9182563
references.citation: Br J Pharmacol. 2011 May;163(2):234-45
references.pmid: 21244373
references.citation: Mol Pharmacol. 2005 Nov;68(5):1291-300
references.pmid: 16103045
references.citation: J Comp Neurol. 2002 Jan 28;443(1):43-55
references.pmid: 11793346
references.citation: J Neurosci. 2005 Nov 16;25(46):10682-8
references.pmid: 16291941
references.citation: Nature. 2011 Jan 20;469(7330):428-31
references.pmid: 21248852
references.citation: Eur J Pharmacol. 2004 Oct 1;500(1-3):441-51
references.pmid: 15464051
references.citation: Nature. 1997 Sep 25;389(6649):385-9
references.pmid: 9311780
references.citation: Curr Top Med Chem. 2011;11(2):241-6
references.pmid: 21189125
references.citation: J Biol Chem. 2001 Sep 28;276(39):36275-80
references.pmid: 11466317
references.citation: Curr Drug Targets CNS Neurol Disord. 2003 Aug;2(4):213-32
references.pmid: 12871032
references.citation: Nat Neurosci. 2000 Jun;3(6):587-92
references.pmid: 10816315
references.citation: J Neurochem. 2008 Sep;106(6):2353-63
references.pmid: 18643789
references.citation: J Biol Chem. 1997 May 2;272(18):11723-7
references.pmid: 9115225
references.citation: Nature. 2006 Nov 23;444(7118):486-9
references.pmid: 17108970
references.citation: J Psychopharmacol. 2011 Mar;25(3):329-44
references.pmid: 20156926
references.citation: Physiol Behav. 1987;41(3):241-5
references.pmid: 2893398
references.citation: J Neurosci. 2006 Nov 8;26(45):11599-605
references.pmid: 17093081
references.citation: Nature. 1999 Oct 21;401(6755):796-800
references.pmid: 10548105
references.citation: Pharmacol Rev. 1995 Jun;47(2):181-234
references.pmid: 7568326
references.citation: Proc Natl Acad Sci U S A. 2002 Jun 25;99(13):8980-5
references.pmid: 12084936
references.citation: Trends Pharmacol Sci. 2000 Jan;21(1):16-9
references.pmid: 10637650
references.citation: Proc Natl Acad Sci U S A. 2003 Nov 25;100(24):14439-44
references.pmid: 14623958
references.citation: Mol Pharmacol. 2004 Jan;65(1):68-76
references.pmid: 14722238
references.citation: J Neurosci. 2003 Sep 17;23(24):8608-17
references.pmid: 13679430
references.citation: Nat Rev Neurosci. 2005 Mar;6(3):215-29
references.pmid: 15738957
references.citation: Neuroscience. 2003;119(4):933-43
references.pmid: 12831854
references.citation: Nature. 2011 Jun 2;474(7349):54-60
references.pmid: 21572436
references.citation: J Physiol. 2006 Dec 15;577(Pt 3):841-56
references.pmid: 17023503
references.citation: Pharmacol Rev. 2008 Sep;60(3):243-60
references.pmid: 18790874
references.citation: Pflugers Arch. 2012 Jan;463(1):187-99
references.pmid: 21735059
references.citation: Nat Rev Neurosci. 2004 Sep;5(9):709-20
references.pmid: 15322529
references.citation: J Neurosci. 1992 Mar;12(3):1040-62
references.pmid: 1312131
references.citation: Anesthesiology. 2007 Sep;107(3):412-8
references.pmid: 17721243
references.citation: Neuroscience. 2000;101(4):815-50
references.pmid: 11113332